DANIPHARM A/S
Company details
- CVR number
- 12335040
- Status
- Active
- Legal form
- Public limited company (A/S)
- Industry
- Fremstilling af farmaceutiske råvarer(211000)
- Founded
- 1 August 1988
- Address
- Englandsvej 350-356, 2770 Kastrup
- Municipality
- Tårnby
Find similar companies in the same industry and build a lead list right inside your AI.
Key figures
The latest 3 financial years from the annual reports. Amounts in Danish kroner (DKK).
| Financial year | 2024/25 | 2023/24 | 2022/23 |
|---|---|---|---|
| Gross profit | DKK 37.6m | DKK 34.1m | DKK 35.2m |
| Net profit | DKK 13.7m | DKK 5.1m | DKK 5.4m |
| Equity | DKK 60.3m | DKK 46.6m | DKK 41.4m |
| Employees (avg.) | 28 | 28 | 28 |
Track the trend via the API.REST API (OpenAPI)
Get all 14 years of financials right inside Claude or ChatGPT via MCP.
Similar companies
Active companies in the same industry and municipality or close in size.
- BIOFAC A/S
2770 Kastrup
77 employees · gross profit DKK 73.6m (2025)
- A/S ORTHANA KEMISK FABRIK
2770 Kastrup
37 employees · gross profit DKK 20.9m (2025)
- CHR. OLESEN SYNTHESIS A/S
2650 Hvidovre
79 employees · gross profit DKK 7.0m (2025)
- ZPD A/S
6700 Esbjerg
48 employees · gross profit DKK 52.7m (2025)
- PHARMA MEDICO ApS
8000 Aarhus C
10 employees · gross profit DKK 32.3m (2025)
- Idun Medica A/S
8930 Randers NØ
4 employees · gross profit DKK 1.5m (2025)
- STENOCARE A/S
3500 Værløse
4 employees · gross profit DKK 1.2m (2025)
- Nordic Life Sciences A/S
5471 Søndersø
4 employees · gross profit -DKK 8.9m (2025)
See all:Fremstilling af farmaceutiske råvarer (32)Tårnby (3,246)
Full financials and history
Lead Strategist is free during the beta with 20,000 credits a month. Get every figure for this company right inside your AI or via the API.
- All 14 financial years in the database
- Balance sheet: assets, liabilities, provisions and cash
- EBIT, gross profit and reporting class
- Auditor and audit firm
Free beta · 20,000 credits a month · no card
By creating an account you accept the terms on behalf of your business.